Joel Ernst, MD, professor of drugs and chief of the division of experimental drugs, UCSF College of Drugs, San Francisco.
Santosha Vardhana, MD, PhD, assistant professor of drugs and attending doctor, Memorial Sloan Kettering Most cancers Middle, New York.
Nicolas Vabret, PhD, assistant professor of drugs, Icahn College of Drugs at Mount Sinai, New York.
Medline Plus: “Immune response.”
Journal of Experimental Drugs: “The various faces of the anti-COVID immune response.”
UCSF: “Ask the Professional: Looking for Immunity Towards COVID-19.”
La Jolla Institute for Immunology: “T Cells Take the Lead in Controlling SARS-COV-2 and Decreasing Covid-19 Severity.”
Cell: “Antigen-Particular Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Illness Severity.”
Immunity: “Immunology of COVID-19: Present State of the Science.”
The Lancet Infectious Ailments: “Genomic proof for reinfection with SARS-CoV-2: a case research,” and “What reinfections imply for COVI-19.”
Johns Hopkins Coronavirus Useful resource Middle.
The Lancet Infectious Illness: “Longitudinal antibody and T cell responses in Ebola virus illness survivors and contacts: an observational cohort research.”
mBio: “Decline of Humoral Responses towards SARS-CoV-2 Spike in Convalescent People.”
Science Immunology: “Persistence and decay of human antibody response to the receptor binding area of SARS-CoV-2 spike protein in COVID-19 sufferers.”
BRO Information: “COVID-19 reinfection tracker.”